Engineering more than a cell: Vascularization strategies in tissue engineering

Current Opinion in Biotechnology

Volumn 21, Issue 5, 2010, Pages 704-709

  Phelps, Edward A ^a   García, Andrés J ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVE SYSTEMS; CELL TRANSPLANTATION; DISEASE STATE; ENGINEERED TISSUES; GROWTH FACTOR; IN-VIVO; MATRIX MATERIALS; NEW TECHNOLOGIES; REPAIR MODELS; ROBUST STRATEGY; TISSUE PERFUSION; VASCULAR RESPONSE; VASCULARIZATION;

HISTOLOGY; TISSUE;

TISSUE ENGINEERING;

BASIC FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; MACROGOL; MATRIGEL; NANOPARTICLE; VASCULOTROPIN;

ANTIANGIOGENIC GENE THERAPY; CHORIOALLANTOIS; CLINICAL TRIAL; ENDOTHELIUM CELL; GENE DELIVERY SYSTEM; HEART MUSCLE ISCHEMIA; HUMAN; HYDROGEL; IMMUNOHISTOCHEMISTRY; ISCHEMIA; LIMB ISCHEMIA; MESENCHYMAL STEM CELL; MICRO-COMPUTED TOMOGRAPHY; MICROFLUIDICS; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN TRANSPORT; REGENERATIVE MEDICINE; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; VASCULARIZATION;

ANIMALS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE ENGINEERING;

EID: 77957353309     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2010.06.005     Document Type: Review

References (47)

1. Nerem R.M. Tissue engineering: the hope, the hype, and the future. Tissue Eng 2006, 12:1143-1150.
2. Kannan R.Y., Salacinski H.J., Sales K., Butler P., Seifalian A.M. The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. Biomaterials 2005, 26:1857-1875.
3. Carmeliet P., Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature 2005, 436:193-200.
4. Gupta R., Tongers J., Losordo D.W. Human studies of angiogenic gene therapy. Circ Res 2009, 105:724-736.
5. Cheng D., Sefton M.V. Dual delivery of placental growth factor and vascular endothelial growth factor from poly(hydroxyethyl methacrylate-co-methyl methacrylate) microcapsules containing doubly transfected luciferase-expressing L929 cells. Tissue Eng Part A 2009, 15:1929-1939.
6. Chen R.R., Silva E.A., Yuen W.W., Mooney D.J. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 2007, 24:258-264.
7. Sarkar K., Fox-Talbot K., Steenbergen C., Bosch-Marce M., Semenza G.L. Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice. Proc Natl Acad Sci USA 2009, 106:18769-18774.
8. Shyu K.G., Wang M.T., Wang B.W., Chang C.C., Leu J.G., Kuan P., Chang H. Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat. Cardiovasc Res 2002, 54:576-583.
9. Sun L., Bai Y., Du G. Endothelial dysfunction-an obstacle of therapeutic angiogenesis. Ageing Res Rev 2009, 8:306-313.
10. Yang F., Cho S.W., Son S.M., Bogatyrev S.R., Singh D., Green J.J., Mei Y., Park S., Bhang S.H., Kim B.S., et al. Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc Natl Acad Sci USA 2010, 107:3317-3322.
11. Koike N., Fukumura D., Gralla O., Au P., Schechner J.S., Jain R.K. Tissue engineering: creation of long-lasting blood vessels. Nature 2004, 428:138-139.
12. Melero-Martin J.M., De Obaldia M.E., Kang S.Y., Khan Z.A., Yuan L., Oettgen P., Bischoff J. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 2008, 103:194-202.
13. Loffredo F., Lee R.T. Therapeutic vasculogenesis: it takes two. Circ Res 2008, 103:128-130.
14. Avci-Adali M., Ziemer G., Wendel H.P. Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization-a review of current strategies. Biotechnol Adv 2010, 28:119-129.
15. Kawamoto A., Iwasaki H., Kusano K., Murayama T., Oyamada A., Silver M., Hulbert C., Gavin M., Hanley A., Ma H., et al. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 2006, 114:2163-2169.
16. Losordo D.W., Schatz R.A., White C.J., Udelson J.E., Veereshwarayya V., Durgin M., Poh K.K., Weinstein R., Kearney M., Chaudhry M., et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 2007, 115:3165-3172.
17. Kawamoto A., Katayama M., Handa N., Kinoshita M., Takano H., Horii M., Sadamoto K., Yokoyama A., Yamanaka T., Onodera R., et al. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells 2009, 27:2857-2864.
18. Kraehenbuehl T.P., Ferreira L.S., Zammaretti P., Hubbell J.A., Langer R. Cell-responsive hydrogel for encapsulation of vascular cells. Biomaterials 2009, 30:4318-4324.
19. Moon J.J., Saik J.E., Poche R.A., Leslie-Barbick J.E., Lee S.H., Smith A.A., Dickinson M.E., West J.L. Biomimetic hydrogels with pro-angiogenic properties. Biomaterials 2010, 31:3840-3847.
20. Leslie-Barbick J.E., Moon J.J., West J.L. Covalently-immobilized vascular endothelial growth factor promotes endothelial cell tubulogenesis in poly(ethylene glycol) diacrylate hydrogels. J Biomater Sci Polym Ed 2009, 20:1763-1779.
21. Phelps E.A., Landázuri N., Thule P.M., Taylor W.R., García A.J. Bioartificial matrices for therapeutic vascularization. Proc Natl Acad Sci USA 2010, 107:3323-3328.
22. Ehrbar M., Zeisberger S.M., Raeber G.P., Hubbell J.A., Schnell C., Zisch A.H. The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis. Biomaterials 2008, 29:1720-1729.
23. Ghanaati S., Webber M.J., Unger R.E., Orth C., Hulvat J.F., Kiehna S.E., Barbeck M., Rasic A., Stupp S.I., Kirkpatrick C.J. Dynamic in vivo biocompatibility of angiogenic peptide amphiphile nanofibers. Biomaterials 2009, 30:6202-6212.
24. Kraehenbuehl T.P., Zammaretti P., Van der Vlies A.J., Schoenmakers R.G., Lutolf M.P., Jaconi M.E., Hubbell J.A. Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell-responsive PEG-hydrogel. Biomaterials 2008, 29:2757-2766.
25. Weber L.M., Anseth K.S. Hydrogel encapsulation environments functionalized with extracellular matrix interactions increase islet insulin secretion. Matrix Biol 2008, 27:667-673.
26. Chung I.M., Enemchukwu N.O., Khaja S.D., Murthy N., Mantalaris A., Garcia A.J. Bioadhesive hydrogel microenvironments to modulate epithelial morphogenesis. Biomaterials 2008, 29:2637-2645.
27. Gupta R., Van Rooijen N., Sefton M.V. Fate of endothelialized modular constructs implanted in an omental pouch in nude rats. Tissue Eng Part A 2009, 15:2875-2887.
28. Kelm J.M., Lorber V., Snedeker J.G., Schmidt D., Broggini-Tenzer A., Weisstanner M., Odermatt B., Mol A., Zund G., Hoerstrup S.P. A novel concept for scaffold-free vessel tissue engineering: self-assembly of microtissue building blocks. J Biotechnol 2010, 148(1):46-55.
29. Sasagawa T., Shimizu T., Sekiya S., Haraguchi Y., Yamato M., Sawa Y., Okano T. Design of prevascularized three-dimensional cell-dense tissues using a cell sheet stacking manipulation technology. Biomaterials 2010, 31:1646-1654.
30. Su D., Zhang N., He J., Qu S., Slusher S., Bottino R., Bertera S., Bromberg J., Dong H.H. Angiopoietin-1 production in islets improves islet engraftment and protects islets from cytokine-induced apoptosis. Diabetes 2007, 56:2274-2283.
31. Cheng Y., Liu Y.F., Zhang J.L., Li T.M., Zhao N. Elevation of vascular endothelial growth factor production and its effect on revascularization and function of graft islets in diabetic rats. World J Gastroenterol 2007, 13:2862-2866.
32. Hussey A.J., Winardi M., Han X.L., Thomas G.P., Penington A.J., Morrison W.A., Knight K.R., Feeney S.J. Seeding of pancreatic islets into prevascularized tissue engineering chambers. Tissue Eng Part A 2009, 15:3823-3833.
33. Hiscox A.M., Stone A.L., Limesand S., Hoying J.B., Williams S.K. An islet-stabilizing implant constructed using a preformed vasculature. Tissue Eng Part A 2008, 14:433-440.
34. Stevens K.R., Pabon L., Muskheli V., Murry C.E. Scaffold-free human cardiac tissue patch created from embryonic stem cells. Tissue Eng Part A 2009, 15:1211-1222.
35. Lesman A., Habib M., Caspi O., Gepstein A., Arbel G., Levenberg S., Gepstein L. Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng Part A 2010, 16:115-125.
36. Dvir T., Kedem A., Ruvinov E., Levy O., Freeman I., Landa N., Holbova R., Feinberg M.S., Dror S., Etzion Y., et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci USA 2009, 106:14990-14995.
37. Shepherd B.R., Hoying J.B., Williams S.K. Microvascular transplantation after acute myocardial infarction. Tissue Eng 2007, 13:2871-2879.
38. Mironov V., Kasyanov V., Drake C., Markwald R.R. Organ printing: promises and challenges. Regen Med 2008, 3:93-103.
39. Visconti R.P., Kasyanov V., Gentile C., Zhang J., Markwald R.R., Mironov V. Towards organ printing: engineering an intra-organ branched vascular tree. Expert Opin Biol Ther 2010, 10:409-420.
40. Moon J.J., Hahn M.S., Kim I., Nsiah B.A., West J.L. Micropatterning of poly(ethylene glycol) diacrylate hydrogels with biomolecules to regulate and guide endothelial morphogenesis. Tissue Eng Part A 2009, 15:579-585.
41. Kloxin A.M., Tibbitt M.W., Kasko A.M., Fairbairn J.A., Anseth K.S. Tunable hydrogels for external manipulation of cellular microenvironments through controlled photodegradation. Adv Mater 2010, 22:61-66.
42. Chung S., Sudo R., Zervantonakis I.K., Rimchala T., Kamm R.D. Surface-treatment-induced three-dimensional capillary morphogenesis in a microfluidic platform. Adv Mater 2009, 21:4863-4867.
43. Jain R.K. Molecular regulation of vessel maturation. Nat Med 2003, 9:685-693.
44. Staton C.A., Reed M.W., Brown N.J. A critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Pathol 2009, 90:195-221.
45. Dietrich F., Lelkes P.I. Fine-tuning of a three-dimensional microcarrier-based angiogenesis assay for the analysis of endothelial-mesenchymal cell co-cultures in fibrin and collagen gels. Angiogenesis 2006, 9:111-125.
46. Duvall C.L., Weiss D., Robinson S.T., Alameddine F.M., Guldberg R.E., Taylor W.R. The role of osteopontin in recovery from hind limb ischemia. Arterioscler Thromb Vasc Biol 2008, 28:290-295.
47. Duvall C.L., Taylor W.R., Weiss D., Guldberg R.E. Quantitative microcomputed tomography analysis of collateral vessel development after ischemic injury. Am J Physiol Heart Circ Physiol 2004, 287:H302-310.